Unknown

Dataset Information

0

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

ABSTRACT:

SUBMITTER: van Manen MJG 

PROVIDER: S-EPMC5678896 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis.
| S-EPMC6416878 | biostudies-literature
Unknown Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients.
| S-EPMC4620844 | biostudies-literature
Unknown Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis.
| S-EPMC8094468 | biostudies-literature
Unknown Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.
| S-EPMC8750555 | biostudies-literature
Unknown Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
| S-EPMC5452370 | biostudies-literature
Unknown A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
| S-EPMC6967289 | biostudies-literature
Unknown Effectiveness of Pharmacist-Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone.
| S-EPMC7725709 | biostudies-literature
Unknown Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.
| S-EPMC6092682 | biostudies-literature
Unknown Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
| S-EPMC4550327 | biostudies-literature
Unknown Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis.
| S-EPMC4230393 | biostudies-literature